Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TissUse
Berlin, Berlin, Germany
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
TissUse has demonstrated key capabilities in systemic human tissue modeling, including successful collaborations to develop advanced disease models such as type 2 diabetes-on-a-chip and tuberculosis screening platforms, reducing the need for animal testing and enhancing preclinical drug development.
- Therapeutic areas
- OncologyOtherDermatologyEndocrinology
- Modalities
- Device (Microfluidic chip)Cell cultureOrganoid
- Industry
- Non-Drug Biotech
02
Partnerships
Beyond the preview
Go deeper on TissUse.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TissUse.